Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Solid Tumor · Uveal Melanoma, Metastatic · Cutaneous Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Herlev and Gentofte Hospital, Center for Cancer Research, Herlev, Denmark

    Contact: Study coordinator (Rikke Eefsen, MD)
  • Institut Catalá de Oncologia - Hospital Duran i Reynals., Barcelona, Spain

    Contact: Study coordinator (José M Piulats Rodríguez, MD, PhD)
  • Fundacion Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (FJD), Madrid, Spain

    Contact: Study coordinator (Victor Moreno, MD PhD)
  • Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain

    Contact: Study coordinator (Emiliano Calvo, MD PhD)
  • Consorcio Hospital General Universitario de Valencia, Valencia, Spain

    Contact: Study coordinator (Alfonso Berrocal, MD. PhD)
Study leads
  • Kristoffer S Rohrberg, MD PhD

    Principal Investigator

    University Hospital of Denmark, Department of Oncology